Vasodilation in black Americans: Attenuated nitric oxide-mediated responses

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 4, 1997, Pages 436-443

  Stein, C Michael ^a   Lang, Chim C ^a   Nelson, Richard ^a   Brown, Michael ^a   Wood, Alastair J J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; METHACHOLINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; AUTOMATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ETHNIC GROUP; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; VOLUNTEER;

ADRENERGIC BETA-AGONISTS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOREARM; HUMANS; ISOPROTERENOL; MALE; METHACHOLINE CHLORIDE; NITRIC OXIDE; NITROPRUSSIDE; REFERENCE VALUES; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 0030722171     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90122-3     Document Type: Article

References (45)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
2. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differences in the impact of hypertension in the United States. Arch Intern Med 1989;149:78-88.
3. Public Health Service, National Center for Health Statistics. Vital Statistics of the United States, 1977: Mortality. Hyattsville, MD: US Department of Health, Education and Welfare; vol II, 1977.
4. Gillum RF. Pathophysiology of hypertension in blacks and whites. Hypertension 1979;1:468-75.
5. Kaplan NM. Ethnic aspects of hypertension. Lancet 1994;344:450-2.
6. Murphy JK, Alpert BS, Moes DM, Somes GW. Race and cardiovascular reactivity: a neglected relationship. Hypertension 1986;8:1075-83.
7. Anderson NB, Myers HF, Pickering T, Jackson JS. Hypertension in blacks: psychosocial and biological perspectives. J Hypertens 1989;7:161-72.
8. Voors AM, Webber LS, Berensen GS. Racial contrasts in cardiovascular response tests for children from a total community. Hypertension 1980;2:686-94.
9. Anderson NB, Lane JD, Muranaka M, Williams RB Jr. Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. Psychosom Med 1988;50:57-63.
10. Falkner B. Is there a black hypertension? Hypertension 1987;10:551-4.
11. Light KC, Obrist PA, Sherwood A, James SA, Strogatz DZ. Effects of race and marginally elevated blood pressure on responses to stress. Hypertension 1987;10:555-63.
12. Lang CC, Stein CM, Brown RM, Deegan D, Nelson R, He HB, et al. Attenuation of isoproterenol-mediated vasodilation in blacks. N Engl J Med 1995; 333:155-60.
13. Luscher TF. Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension. Am J Hypertens 1990;3:317-30.
14. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
15. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
16. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988;153: 1251-6.
17. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990;30:535-60.
18. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
19. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
20. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
21. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of hypertension. Hypertension 1993;21:929-33.
22. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84:1589-96.
23. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
24. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993;88:2541-7.
25. Naslund T, Silbertstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in β-receptor mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin Pharmacol Ther 1990;48:87-95.
26. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990;85: 647-52.
27. Stein CM, Nelson R, Deegan R, He HB, Wood M, Wood AJJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995;26:705-10.
28. Workman RJ, Sussman CR, Burkitt DW, Liddle GR. Circulating levels of angiotensin I measured by radioimmunoassay in hypertensive subjects. J Lab Clin Med 1979;93:847-56.
29. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
30. 2, and prostanoid receptor responses. Clin Pharmacol Ther 1990;47:360-5.
31. 2-adrenoceptor density could explain reported differences in basal lymphocyte cAMP production in two ethnic groups. Med Sci Res 1993;21: 313-4.
32. Venter CP, Daya S, Joubert PH, Strydom WJ. Ethnic differences in human lymphocyte cyclic AMP production after isoprenaline stimulation and propranolol blockade. Br J Clin Pharmacol 1985;19:187-90.
33. 2-adrenergic receptors. Hypertension 1995;25:88-91.
34. 2c10-adrenergic receptor genotype. Hypertension 1996;27:1210-5.
35. Feldman RD. β-Adrenergic receptor alterations in hypertension: physiological and molecular correlates. Can J Physiol Pharmacol 1987;65:1666-72.
36. Aviv A, Gardner J. Racial differences in ion regulation and their possible links to hypertension in blacks. Hypertension 1989;14:584-9.
37. Kimura M, Cho JH, Lasker N, Aviv A. Differences in platelet calcium regulation between African Americans and Caucasians: implications for the predisposition of African Americans to essential hypertension. J Hypertens 1994;12:199-207.
38. Cho JH, Nash F, Fekete Z, Kimura M, Reeves JP, Aviv A. Increased calcium stores in platelets from African Americans. Hypertension 1995;25:377-83.
39. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA. Stimulatory effect of β-adrenergic agonists on endothelium-derived nitric oxide activity in humans [abstract]. Circulation 1996;94:I-6.
40. Dawes M, Chowienczyk PJ, Ritter JM. Inhibition of nitric oxide (NO) synthesis in the human forearm selectively inhibits β-adrenergic vasodilation [abstract]. Circulation 1996;94:I-522.
41. Eichler HG, Blashke TF, Hoffman BB. Decreased responsiveness of superficial hand veins to phenylephrine in black normotensive males. J Cardiovasc Pharmacol 1990;16:177-81.
42. Stein CM, Deegan R, Wood AJJ. Lack of correlation between arterial and venous beta adrenergic receptor sensitivity. Hypertension 1997;29:1273-7.
43. Basset Jr DR, Duey WJ, Walker AJ, Howley EJ, Bond V. Racial differences in maximal vasodilatory capacity of forearm resistance vessels in normotensive young adults. Am J Hypertens 1992;5:781-6.
44. Carlsson I, Sollevi A, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human reactive hyperemia. J Physiol (Lond) 1987; 389:147-61.
45. Stein M, Deegan R, He H, Wood AJJ. β-Adrenergic receptor-mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther 1993;54:58-64.